Evidence map›Paper›PMID 33644875›Full record

ArticleThe EMBO journal2021

A weakened interface in the P182L variant of HSP27 associated with severe Charcot-Marie-Tooth neuropathy causes aberrant binding to interacting proteins.

T Reid Alderson, Elias Adriaenssens, Bob Asselbergh, Iva Pritišanac, Jonas Van Lent, Heidi Y Gastall, Marielle A Wälti, John M Louis, Vincent Timmerman, Andrew J Baldwin and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The role of BAG3 in dilated cardiomyopathy and its association with Charcot-Marie-Tooth disease type 2.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2022
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

T Reid AldersonChemistry Research Laboratory, University of Oxford, Oxford, UK.ORCID 0000-0001-5163-2276
Elias AdriaenssensPeripheral Neuropathy Research Group, Department of Biomedical Sciences, Institute Born Bunge, University of Antwerp, Antwerpen, Belgium.ORCID 0000-0001-9430-917X
Bob AsselberghNeuromics Support Facility, VIB Center for Molecular Neurology, VIB, Antwerpen, Belgium.ORCID 0000-0003-2784-2470
Iva PritišanacMolecular Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada.ORCID 0000-0002-9152-6555
Jonas Van LentPeripheral Neuropathy Research Group, Department of Biomedical Sciences, Institute Born Bunge, University of Antwerp, Antwerpen, Belgium.
Heidi Y GastallChemistry Research Laboratory, University of Oxford, Oxford, UK.
Marielle A WältiLaboratory of Chemical Physics, National Institutes of Health, Bethesda, MD, USA.
John M LouisLaboratory of Chemical Physics, National Institutes of Health, Bethesda, MD, USA.
Vincent TimmermanPeripheral Neuropathy Research Group, Department of Biomedical Sciences, Institute Born Bunge, University of Antwerp, Antwerpen, Belgium.ORCID 0000-0002-2162-0933
Andrew J BaldwinChemistry Research Laboratory, University of Oxford, Oxford, UK.ORCID 0000-0001-7579-8844
Justin Lp BeneschChemistry Research Laboratory, University of Oxford, Oxford, UK.ORCID 0000-0002-1507-3742
University of Antwerp · BENational Institutes of Health · USUniversity of Oxford · GBHospital for Sick Children · CA

Funding

Biotechnology and Biological Sciences Research Council BB/J014346/1Biotechnology and Biological Sciences Research Council BB/J018082/1
6 · The paper itself

Abstract

HSP27 is a human molecular chaperone that forms large, dynamic oligomers and functions in many aspects of cellular homeostasis. Mutations in HSP27 cause Charcot-Marie-Tooth (CMT) disease, the most common inherited disorder of the peripheral nervous system. A particularly severe form of CMT disease is triggered by the P182L mutation in the highly conserved IxI/V motif of the disordered C-terminal region, which interacts weakly with the structured core domain of HSP27. Here, we observed that the P182L mutation disrupts the chaperone activity and significantly increases the size of HSP27 oligomers formed in vivo, including in motor neurons differentiated from CMT patient-derived stem cells. Using NMR spectroscopy, we determined that the P182L mutation decreases the affinity of the HSP27 IxI/V motif for its own core domain, leaving this binding site more accessible for other IxI/V-containing proteins. We identified multiple IxI/V-bearing proteins that bind with higher affinity to the P182L variant due to the increased availability of the IxI/V-binding site. Our results provide a mechanistic basis for the impact of the P182L mutation on HSP27 and suggest that the IxI/V motif plays an important, regulatory role in modulating protein-protein interactions.

Indexed as

AdultBinding SitesCells, CulturedCharcot-Marie-Tooth DiseaseHeat-Shock ProteinsHeLa CellsHumansInduced Pluripotent Stem CellsMaleMolecular ChaperonesMolecular Dynamics SimulationMotor NeuronsMutation, MissenseProtein BindingProtein MultimerizationHeat-Shock ProteinsHSPB1 protein, humanMolecular Chaperonescharcot-marie-tooth diseaseintrinsically disordered regionsmolecular chaperonesNMR spectroscopyshort linear motif

Identifiers

PMID33644875
PMCPMC8047445
OpenAlexW3135058903

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.